Related Experiment Videos
[Levamisole as an immunostimulating factor].
Problemy Medycyny Wieku Rozwojowego
|January 1, 1979
Summary
Levamisole restores cell-mediated immunity in immunodepressed patients, acting as an antianergic agent. This immunostimulant enhances phagocytosis and chemotaxis, improving long-term survival in cancer models.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Context:
- Levamisole, initially an antihelmintic, is recognized for its immunomodulatory properties.
- Its classification as a nonspecific immunostimulant requires clarification due to its specific mechanism of action.
Purpose:
- To elucidate the precise role of levamisole as an antianergic chemotherapeutic agent.
- To investigate levamisole's effects on cell-mediated immunity, phagocytosis, and chemotaxis.
Summary:
- Levamisole restores cell-mediated immunity in immunodepressed individuals, unlike typical immunostimulants.
- It enhances phagocytic activity of macrophages and polymorphonuclear cells, particularly in hypofunctional states.
- Levamisole improves chemotactic responsiveness in patients with defective leukocyte motility and restores leucocyte migration inhibition.
Impact:
- Levamisole prolongs remission periods and increases long-term survival rates as an adjunct therapy in animal cancer models.
- Demonstrates potential in treating conditions characterized by immunodeficiency and defective immune cell function.
- Highlights levamisole's therapeutic value beyond its antihelmintic applications.